HansBiomed Corporation (KOSDAQ: 042520)

HansBiomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is October - September.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Market Capitalization	95,065	207,570	92,964	160,691	226,346	206,744
Market Cap Growth	-35.61%	123.28%	-42.15%	-29.01%	9.48%	-30.08%
Enterprise Value	121,060	241,607	132,643	187,080	248,070	217,340
Last Close Price	7320.00	17930.00	9610.00	16050.00	22850.00	21850.00
PE Ratio	-	-	53.28	-	-	21.59
Forward PE	-	6.95	6.95	6.95	18.36	19.08
PS Ratio	1.14	2.66	1.25	2.72	2.83	3.09
PB Ratio	1.29	4.16	1.96	3.38	3.27	2.46
P/TBV Ratio	2.07	4.29	2.08	3.70	3.98	3.16
P/OCF Ratio	97.28	-	-	-	39.36	26.80
EV/Sales Ratio	1.50	3.10	1.78	3.17	3.10	3.24
EV/EBITDA Ratio	90.26	231.57	21.54	-	1203.72	15.17
EV/EBIT Ratio	-	-	105.60	-	-	17.29
EV/FCF Ratio	-148.87	-	-	-	-	-
Debt / Equity Ratio	0.45	0.82	1.18	1.08	0.47	0.40
Debt / EBITDA Ratio	11.25	39.43	9.08	-	159.38	2.35
Asset Turnover	0.64	0.61	0.57	0.45	0.60	0.59
Inventory Turnover	1.12	1.20	1.26	1.64	2.28	1.95
Quick Ratio	0.45	0.31	0.32	0.49	1.36	1.69
Current Ratio	1.10	0.77	0.73	0.84	2.09	2.43
Return on Equity (ROE)	-15.81%	-49.47%	10.36%	-37.86%	-23.70%	12.38%
Return on Assets (ROA)	-1.16%	-2.04%	0.60%	-9.46%	-1.60%	6.96%
Return on Capital (ROIC)	-1.40%	-2.67%	0.78%	-12.28%	-1.94%	7.89%
Earnings Yield	-10.28%	-11.10%	6.61%	-11.38%	-7.88%	4.81%
FCF Yield	-0.86%	-2.73%	-8.88%	-12.16%	-0.57%	-3.80%
Dividend Yield	0.00%	-	-	-	-	0.55%
Payout Ratio	0.00%	-	-	-	-	9.87%
Buyback Yield / Dilution	-22.39%	18.41%	-31.21%	-1.48%	-0.37%	-1.98%
Total Shareholder Return	-22.39%	18.41%	-31.21%	-1.48%	-0.37%	-1.43%

Source: S&P Capital IQ. Standard template. Financial Sources.